REGISTER
OCC 2026 | Can We Prevent Vascular Aging?
This roundtable explores vascular aging prevention: Dr. John P. Cooke states biological vascular aging is modifiable, while Prof. Yi Li predicts AI and digital twins will build early risk models with multi-dimensional vascular indicators.


In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Pan-Vascular Disease · Integration: From Single Organ to Systemic Management”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and Prof. Lingcong Kong, Renji Hospital, Shanghai Jiao Tong University School of Medicine. Quest for Truth is honored to welcome two distinguished guest speakers: Dr. John P. Cooke, Stanford Medicine; and Prof. Yi Li, The First Affiliated Hospital, Sun Yat-sen University.

In this segment, Prof. Gang Wu asks both experts to look ahead: will the next transformation in pan-vascular medicine come from technological breakthroughs, or from a deeper shift in how physicians define disease and organize care? The discussion turns to the future of vascular biology, aging, AI, and predictive prevention.

Dr. John P. Cooke highlights vascular aging as one of the most important frontiers. He explains that while chronological age cannot be changed, aging processes themselves may be modifiable. With growing understanding of cellular senescence, inflammation, proteostasis impairment, mitochondrial dysfunction, and DNA damage, he anticipates that future clinical trials may show how modifying aging biology can reshape cardiovascular care.

Prof. Yi Li points to the role of advanced devices, AI, and digital twins in future pan-vascular prevention. By integrating cholesterol levels, lifestyle data, inflammatory markers, ABI, arterial stiffness, and other vascular indicators, clinicians may one day build predictive models that help patients understand future risk and act earlier. He suggests that this could move vascular medicine toward a future where people live longer with healthier arteries.

0
0
Loading